Switch Therapeutics Stock

Switch Therapeutics is a biotech company that develops RNAi therapies.

Sign up today and learn more about Switch Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Switch Therapeutics Stock

Switch Therapeutics is a biotech company that develops RNAi therapies based on technology. The company was founded in 2020 and is based in San Francisco, California, United States.

Funding History

March 2023$52.0M

Management

Founder and CEO

Dee Datta

Co-founder and CTO

Si-ping Han

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo